These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6394042)

  • 1. Autologous bone marrow transplantation contributes to haemopoietic recovery in children with solid tumours treated with high dose melphalan.
    Kingston JE; Malpas JS; Stiller CA; Pritchard J; McElwain TJ
    Br J Haematol; 1984 Dec; 58(4):589-95. PubMed ID: 6394042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer.
    Lazarus HM; Herzig RH; Graham-Pole J; Wolff SN; Phillips GL; Strandjord S; Hurd D; Forman W; Gordon EM; Coccia P
    J Clin Oncol; 1983 Jun; 1(6):359-67. PubMed ID: 6366139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Busulphan and melphalan prior to autologous bone marrow transplantation.
    Srivastava A; Bradstock KF; Szer J; de Bortoli L; Gottlieb DJ
    Bone Marrow Transplant; 1993 Oct; 12(4):323-9. PubMed ID: 8275031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic recovery following autologous bone marrow transplantation: role of cryopreservation, number of cells infused and nature of high-dose chemotherapy.
    Hartmann O; Beaujean F; Bayet S; Pico JL; Tournade MF; Lemerle ; Parmentier C
    Eur J Cancer Clin Oncol; 1985 Jan; 21(1):53-60. PubMed ID: 3882431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan.
    McElwain TJ; Hedley DW; Burton G; Clink HM; Gordon MY; Jarman M; Juttner CA; Millar JL; Milsted RA; Prentice G; Smith IE; Spence D; Woods M
    Br J Cancer; 1979 Jul; 40(1):72-80. PubMed ID: 383125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose melphalan with autologous bone marrow rescue for the treatment of advanced adult solid tumors.
    Maraninchi D; Abecasis M; Gastaut JA; Herve P; Sebahoun G; Flesch M; Blanc AP; Carcassonne Y
    Cancer Treat Rep; 1984 Mar; 68(3):471-4. PubMed ID: 6367977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-intensive therapy in high-risk multiple myeloma.
    Harousseau JL; Milpied N; Laporte JP; Collombat P; Facon T; Tigaud JD; Casassus P; Guilhot F; Ifrah N; Gandhour C
    Blood; 1992 Jun; 79(11):2827-33. PubMed ID: 1350228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose melphalan and non-cryopreserved autologous bone marrow treatment of malignant melanoma and neuroblastoma.
    McElwain TJ; Hedley DW; Gordon MY; Jarman M; Millar JL; Pritchard J
    Exp Hematol; 1979; 7 Suppl 5():360-71. PubMed ID: 400698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.
    Valteau-Couanet D; Vassal G; Pondarré C; Bonnay M; Benhamou E; Couanet D; Plantaz D; Hartmann O
    Bone Marrow Transplant; 1996 Apr; 17(4):485-9. PubMed ID: 8722343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total-body irradiation and melphalan is a safe and effective conditioning regimen for autologous bone marrow transplantation in children with acute myeloid leukemia in first remission. The Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplantation Group.
    Bonetti F; Zecca M; Pession A; Messina C; Montagna D; Lanino E; Fagioli F; Santoro N; Prete A; Cesaro S; Rondelli R; Giorgiani G; De Stefano P; Locatelli F
    J Clin Oncol; 1999 Dec; 17(12):3729-35. PubMed ID: 10577844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
    Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
    Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of metastatic malignant melanoma with intensive melphalan and autologous bone marrow transplantation.
    Lazarus HM; Herzig RH; Wolff SN; Phillips GL; Spitzer TR; Fay JW; Herzig GP
    Cancer Treat Rep; 1985 May; 69(5):473-7. PubMed ID: 3891085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study.
    Lazarus HM; Gray R; Ciobanu N; Winter J; Weiner RS
    Bone Marrow Transplant; 1994 Sep; 14(3):443-8. PubMed ID: 7994270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of advanced neuroblastoma with high-dose melphalan and autologous bone marrow transplantation.
    Hartmann O; Kalifa C; Benhamou E; Patte C; Flamant F; Jullien C; Beaujean F; Lemerle J
    Cancer Chemother Pharmacol; 1986; 16(2):165-9. PubMed ID: 3512113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma.
    Pritchard J; McElwain TJ; Graham-Pole J
    Br J Cancer; 1982 Jan; 45(1):86-94. PubMed ID: 7037033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.
    Cesaro S; Meloni G; Messina C; Pillon M; Proglia A; Lanino E; Caniggia M; Bagnulo S; Pession A; Locatelli F;
    Bone Marrow Transplant; 2001 Jul; 28(2):131-6. PubMed ID: 11509930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Total body irradiation, vincristine in continuous infusion and high-dose melphalan with transplant of autologous bone marrow in the treatment of neuroblastoma].
    Dini G; Garaventa A; Lanino E; Perin GP; Scarpati D; Viscoli C; Franchini E; Corvò R; Dallorso S; Cinollo G
    Pediatr Med Chir; 1987; 9(1):1-7. PubMed ID: 3306621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of high-dose melphalan and autologous bone marrow transplantation for metastatic colon carcinoma.
    Leff RS; Thompson JM; Johnson DB; Mosley KR; Daly MB; Knight WA; Ruxer RL; Messerschmidt GL
    J Clin Oncol; 1986 Nov; 4(11):1586-91. PubMed ID: 3534154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of blood and bone marrow stem cells following intense chemotherapy and autologous bone marrow transplantation.
    Thomas MR; Robinson WA; Mughal TI; Morton N; Glode LM
    Oncology; 1986; 43(5):273-7. PubMed ID: 3531952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients.
    Schmitz N; Linch DC; Dreger P; Goldstone AH; Boogaerts MA; Ferrant A; Demuynck HM; Link H; Zander A; Barge A
    Lancet; 1996 Feb; 347(8998):353-7. PubMed ID: 8598700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.